CD19 and leukemia: To further investigate the association between PSMB9 expression levels and clinical outcomes of CAR-T cell therapy, we evaluated the bulk RNA sequencing data of leukemia-infiltrated bone marrow samples collected prior to CD19 CAR-T therapy from a previously reported study [38].